InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Mendel Scott, Directeur. Insider active across 4 companies, notably Akoya Biosciences, Inc.. Aggregated, 10 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €191k. Activity tracked since 19 November 2021. The latest transaction was disclosed on 1 April 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
8,073 sharesCommon StockSEC:0001515051-26-000004:0
4,310 shares0Common StockSEC:0001515051-26-000002:0
23,372 shares0Common StockSEC:0001515051-26-000001:0
2,084 shares@ US$5.54100.0% of flowCommon StockSEC:0001515051-25-000003:0
4,189 sharesCommon StockSEC:0001562180-25-005379:0
28,500 sharesCommon StockSEC:0001062993-25-012732:0
20,000 shares@ US$5.0032.1% of flowCommon StockSEC:0001104659-23-070483:0
Canonical exit: 10 Sept 2023 (T+90)
141,843 shares0Class A Common StockSEC:0001140361-23-025054:0
8,500 shares@ US$13.1650.0% of flowCommon StockSEC:0001104659-21-141727:0
Canonical exit: 17 Feb 2022 (T+90)
298 sharesCommon StockSEC:0001487371-16-000193:0
10 of 10 declarations
About Mendel Scott
Scott Mendel is a Director at Akoya Biosciences, Inc. He contributes to the governance and strategy of the company. Akoya Biosciences, Inc. specializes in cellular biology solutions.
